Summit Global Investments’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$922K Buy
20,017
+15,228
+318% +$734K 0.05% 240
2026
Q2
$281K Buy
+4,789
New +$201K 0.02% 463
2026
Q1
– Sell
-5,886
Closed -$248K – 537
2025
Q4
$248K Sell
5,886
-3,885
-40% -$157K 0.01% 436
2025
Q3
$335K Buy
+9,771
New +$280K 0.02% 380
2021
Q2
– Sell
-4,100
Closed -$220K – 631
2021
Q1
$220K Buy
+4,100
New +$236K 0.01% 507

Other funds holding VCYT

Summit Global Investments's VCYT Position: Q3 2026 in Review

Summit Global Investments increased its Veracyte (VCYT) stake by 318% in Q3 2026, buying an estimated $734K and bringing the position to 20,017 shares worth $922K. The position accounts for 0.05% of the portfolio, ranked #240.

Summit Global Investments first reported a position in VCYT in Q1 2021 and has held it in 5 quarters since. 245 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Summit Global Investments held 20,017 shares of Veracyte worth $922K as of Q3 2026.
  • Summit Global Investments bought 15,228 Veracyte shares in Q3 2026, an estimated $734K.
  • Veracyte made up 0.05% of Summit Global Investments's portfolio in Q3 2026, its #240 holding.
  • Summit Global Investments first reported a position in Veracyte in Q1 2021 and has held it in 5 quarters since.
  • 245 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Summit Global Investments's 13F filing for Q3 2026, filed 28 Oct 2026.